The Denver-Boulder Life Sciences Market Report Q2 2026 from Savills shows the region’s life sciences sector is normalizing after a period of rapid expansion.
Overall vacancy declined 320 basis points year over year to 23.8% from 27.0% in Q2 2025, while direct vacancy, sublease vacancy and total available space also decreased over the same period. Overall, the report suggests that the market is transitioning from an oversupplied phase toward a more balanced environment, with future growth likely to be driven by targeted leasing and continued investment in emerging life sciences companies.
Market Highlights
- The University of Denver is developing a $112-million, 73,000-square-foot Integrative Life Sciences Center to address growing demand for modern wet laboratory space following increased research funding.
- CU Boulder researchers and university-affiliated startups secured $2.2 million in state Advanced Industries funding, including awards for gene therapy, cell and gene therapy manufacturing and regenerative medicine platforms.
Click here to read more.
